MPPE1 and neoplasm: As the most extensively studied subset of DCs, cDC1 can phagocytose exogenous antigens and other cellular debris released by tumors, and cross-present on major histocompatibility complex class I (MHC-I) to prime tumor-specific CD8+T cells (67).